AMPE News and Press, Ampio Pharmaceuticals Inc. From 12/24/20

Gainers: Avinger (AVGR) +71%, Neoleukin Therapeutics (NLTX) +33%, Ampio Pharmaceuticals (AMPE) +25%, Odonate Therapeutics (ODT) +14%, INmune Bio (INMB) +9%.Losers: Jaguar Health (JAGX) -29%, Ocugen (OCGN) -23%, Second Sight Medical Produc...

SIFCO Industries (SIF) +54% on Q4 results.Creative Realities (CREX) +21%.Triterras (TRIT) +19%.AIM ImmunoTech (AIM) +17%.Bridgetown Holdings Limited (BTWN) +16%.Lightbridge Corporation (LTBR) +24% after nabbing patent in Eurasia for nuclear fuel assemblies.IZEA Worldwide (IZEA) +15%...

A funny thing happened on the way to the Christmas holidays and the end of the final quarter of 2020. All of a sudden, out of the blue, shares of multiple unrelated stocks began to sell off. As the final hour of trading got under way Wednesday, shares of database software company Mong...

Lizhi (LIZI) +29%.Ekso Bionics Holdings (EKSO) +25%.AgEagle Aerial Systems (UAVS) +22%.ENGlobal Corporation (ENG) +23%.Supernus Pharmaceuticals (SUPN) +23%.Scopus BioPharma (SCPS) +21%.Mogo (MOGO) +18%.Magnite (MGNI) +18%.Kopin Corporation (KOPN) +18%.Magna International (MGA) +18%.InMed Phar...

As December winds down, investors continue keeping a close eye on penny stocks . While trading may seem closed off to only professionals, these cheap stocks are some of the most accessible securities out there. For one, penny stocks are any stock trading below the $5 threshold. This mea...

CNS Pharmaceuticals (CNSP) +62%.Cyclo Therapeutics (CYTH) +47%.Mereo BioPharma Group (MREO) +38% on licensing pact with Ultragenyx.DermTech (DMTK) +23% after announcing topline results from its TRUST Study of the company’s non-invasive melanoma rule-out test, the Pigmented Le...

Penny Stocks To Watch Before Next Week Penny stocks are well-known for being high risk. When it comes time to buy them, there are plenty of different emotions that come about. Though it’s important to keep emotion out of trading, sometimes you can’t help but let it slip. T...

Ampio Pharmaceuticals ([[AMPE]] +4.3%) has completed its Phase 1 clinical trial and has initiated the first steps for a global Phase 2 clinical trial for intravenous ((IV)) Ampion treatment in COVID-19 patients.Based on data review, the Safety Monitoring Committee found the IV treatment ...

Ampion Demonstrates Safety In COVID-19 Patients And Initiates Global Clinical Trial For Intravenous Ampion ENGLEWOOD, Colo. , Dec. 17, 2020 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), a biopharmaceutical company focused on the advancement...

AnPac Bio-Medical Science (ANPC) +99% as company makes significant progress in detecting pre-cancer diseases.Arvinas (ARVN) +74% after releasing interim clinical data of PROTAC® protein degraders.Veru (VERU) +57% on positive phase 2 clinical trial results for Enobosarm.Syn...